Annual Rebalancing
EUR
Moderate Risk
1.5yr backtest

Performance Summary

Total Return+23.69%
Annualized Return+15.25%
Volatility+14.34%
Sharpe Ratio0.92
Max Drawdown+17.74%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Globally diversified EUR ETF portfolio with annual rebalancing, blending core holdings with strategic bets on emerging markets and leveraged assets.
AssetTypeAllocationTER
FWIA.XETRA
Invesco FTSE All-World UCITS ETF AccIE000716YHJ7
ETF
30.0%0.15%
AVWC.XETRA
Avantis Global Equity UCITS ETF USD AccIE000RJECXS5
ETF
25.0%0.22%
AVWS.XETRA
Avantis Global Small Cap Value UCITS ETF USD AccIE0003R87OG3
ETF
15.0%0.39%
AVEM.XETRA
Avantis Emerging Markets Equity UCITS ETF USD AccIE000K975W13
ETF
10.0%0.35%
ROX.XETRA
Expat Romania BET UCITS ETFBGROBET05176
ETF
10.0%1.38%
2BRE.XETRA
Leverage Shares 2x Long Berkshire Hathaway (BRK-B) ETPXS2399369110
ETF
10.0%0.75%
Total100.0%0.41%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €12,368.7
Histogram of Monthly Returns
The portfolio had a positive return during 14 of the 19 months (74%)
Monthly Returns Heatmap
Best month: +6.2% • Worst month: -5.3% • Best year: 2026 (+14.0%) • Worst year: 2024 (-3.2%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.6%+4.2%-5.3%+6.2%+4.8%+1.2%------+14.0%
2025+4.4%-0.2%-4.8%-4.5%+4.0%+0.0%+4.1%+1.8%+1.8%+2.6%+2.0%+0.6%+12.0%
2024------------3.2%-3.2%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +17.74% • The longest drawdown period lasted for 6 months and was between February 2025 and September 2025. It reached a trough of -17.7%.

Detailed Metrics

Returns
Total Return
+23.69%
Annualized Return
+15.25%
Avg Monthly Return
+1.18%
Risk
Volatility (Annual)
+14.34%
Max Drawdown
+17.74%
Positive Months
74%
Average Drawdown
-3.5%
Risk-Adjusted
Sharpe Ratio
0.92
Risk-free rate: 2.0%
Sortino Ratio
0.85
Downside risk adjusted
Return/Volatility
1.06
Calmar Ratio
0.86
Return/Max Drawdown
Ulcer Index
4.50
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
12,368.7
Backtest Period
2024-12-12 to 2026-06-12
1.5 years
Rebalancing
annual
Base Currency
EUR
test | +15.3% CAGR | ETF Backtest